Patent details

Basic Information

Publication number:

EP1638552

PCT Application Number:

PCT/US/2004/019543

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP047767579

PCT Publication Number:

WO/2005/002572

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF (3.2.0) HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF FOR THE TREATMENT OF CANCER

French Title of Invention:

UTILISATION DE COMPOSES (3.2.0) HETEROCYCLIQUES ET D'ANALOGUES CORRESPONDANTS POUR LE TRAITEMENT DU CANCER

German Title of Invention:

VERWENDUNG VON (3.2.0) HETEROCYCLISCHEN VERBINDUNGEN UND IHREN ANALOGA ZUR BEHANDLUNG VON KREBS

SPC Number:

Dates

Filing date:

18/06/2004

Grant date:

02/03/2011

EP Publication Date:

02/03/2011

PCT Publication Date:

13/01/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/03/2006

EP B1 Publication Date:

02/03/2011

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/06/2011

Expiration date:

18/06/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/06/2004

 

 

Name:

Nereus Pharmaceuticals Inc.

Address:

10480 Wateridge Circle, San Diego, CA 92121, United States (US)

Inventor

1

Name:

PALLADINO Michael

Address:

United States (US)

2

Name:

NEUTEBOOM Saskia, Theodora, Cornelia

Address:

United States (US)

3

Name:

MACHERLA Venkata, Rami, Reddy

Address:

United States (US)

4

Name:

POTTS Barbara, Christine

Address:

United States (US)

Priority

1

Priority Number:

480270 P

Priority Date:

20/06/2003

Priority Country:

United States (US)

2

Priority Number:

566952 P

Priority Date:

30/04/2004

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/407;

Filing date	Document type	Number of pages